Before COVID-19, there was a growing concern that many individuals who suffer from osteoporosis had experienced adverse issues with prescribed medications, and were therefore avoiding seeking treatment. Now, with the disruption to the health system by the pandemic, the situation has only gotten more complicated, and potentially dangerous, for these patients.
For that reason we thought it would be good to update our article from last year to include new clinical guidance on managing osteoporosis patients that takes the so-called "new normal" into account. |
AuthorsWe're the staff and volunteers at Jackson Orthopedic Foundation, committed to improving the lives of patients with musculoskeletal conditions through education, research and service. Archives
August 2022
Categories
All
|
RSS Feed
